I am a global health researcher working on health economics and health systems analyses. I specialise in economic evaluation and priority setting research in health-related interventions. My work aims to inform policy decisions through quantitative and qualitative methods. I am currently working on three broad areas. The first is health benefit package design and capacity strengthening in health technology assessment in low- and middle-income settings through the International Decision Support Initiative (iDSI). The second is designing and carrying out ‘early’ economic evaluations to estimate the cost-effectiveness of HIV prevention technologies currently in the development pipeline with the intention of informing product development choices. The third is the economic evaluation of intersectoral interventions with outcomes beyond the health sector (e.g., economic empowerment).

I have worked across a range of settings and health areas over my 12+ years of global health research. Selected projects include: cost and cost-effectiveness analyses of COVID-19 treatment and vaccination; technical assistance of health benefit package design in Pakistan; trial-based economic evaluations of HIV interventions (enhanced demand creation to increase uptake of voluntary medical male circumcision in Tanzania, cotrimoxazole preventive therapy discontinuation among HIV-positive adults in Uganda); cross-country assessments of cost and cost-effectiveness of interventions to prevent violence against women and girls (Ghana, Rwanda and Pakistan); analyses of health system distribution of antiretrovirals and antimalarials (Botswana and Madagascar); health system evaluations of new vaccine introductions (Cameroon, Rwanda, Ethiopia); cost analyses of HIV point-of-care diagnostics (Tanzania and Zambia) and explorations of substance use in high-risk populations (UK).

My doctoral research focused on the economic evidence and policy processes of disinvestment in healthcare in low- and middle-income settings. I am originally from Colombia.